| Bioactivity | Omidenepag,a pharmacologically active form of Omidenepag Isopropyl, is a selective, non-prostanoid EP2 receptor agonist, with an EC50 of 1.1 nM. Omidenepag shows binding affinities (IC50) 10 nM for h-EP2[1]. | ||||||||||||
| Name | Omidenepag | ||||||||||||
| CAS | 1187451-41-7 | ||||||||||||
| Formula | C23H22N6O4S | ||||||||||||
| Molar Mass | 478.52 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Iwamura R, et al. Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl. J Med Chem. 2018 Aug 9;61(15):6869-6891. |
Omidenepag
CAS: 1187451-41-7 F: C23H22N6O4S W: 478.52
Omidenepag,a pharmacologically active form of Omidenepag Isopropyl, is a selective, non-prostanoid EP2 receptor agonist,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.